Company intelligence / Profile preview

BTI France

Mérignac, Nouvelle-Aquitaine, France

Ownership: Private
Employees: ~5
Development stage: Other

Overview

BTI France is the French subsidiary of BTI Biotechnology Institute, a Spanish multinational biomedical company specializing in oral implantology, regenerative medicine, and sleep disorders. The company is a pioneer in autologous therapies, notably through its patented Endoret (PRGF - Plasma Rich in Growth Factors) technology, which utilizes the patient's own blood to promote tissue healing and regeneration. BTI France distributes a comprehensive range of dental implants, prosthetic abutments, and regenerative medicine kits to healthcare professionals across France. Additionally, the company provides specialized clinical training and support for its regenerative and implantology systems.

Therapeutic areas: PulmonologyOtherRheumatologyDermatologyOphthalmology
Modalities: Cell therapyBiologicDevice
Industry: Pharma

Beyond the preview

Go deeper on BTI France.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BTI France.

Explore the full profile